Ajeeta B. Dash

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

Ross Tubo, Robert A. Weinberg, Kornelia Polyak, 2007, Nature.

Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack of distinction.

L. Shihabuddin, Ajeeta B. Dash, R. Tubo, 2002, Tissue engineering.

Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors

D. Faller, Carrie Lee, A. Lockhart, 2018, Investigational new drugs.

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.

D. Faller, W. Tam, M. Maris, 2018, Blood.

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9

D. Housman, J. Kutok, M. Tomasson, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration

Trevor J Pugh, T. Pugh, D. Auclair, 2021, Clinical Cancer Research.

Pevonedistat (MLN4924), an Investigational, First-in-Class NAE Inhibitor, in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML) Considered Unfit for Conventional Chemotherapy: Updated Results from the Phase 1 C15009 Trial

M. Maris, H. Erba, B. Dezube, 2014 .